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Summary. Background: The authors want to evaluate the efficacy of fibrillary tabotamp dressing in skin graft-
donor site. A comparison was made with Vaseline gauzes. Tabotamp is an absorbable haemostatic product 
of Ethicon ( Johnson and Johnson) obtained by sterile and oxidized regenerated cellulose (Rayon). It is used 
for mild to moderate bleeding. Materials and methods: 276 patients were subject to skin graft and divided 
into two group: Group A and Group B. The donor site of patients in Group A was medicated with fibrillary 
tabotamp, while the patients of Group B were medicated only with Vaseline gauze. We recorded infection, 
timing of healing, number of dressing change, the pain felt during and after the dressing change with visual 
analog scale (VAS) and a questionnaire. Results: Patients allocated in Group A healed faster than the Group 
B. Questionnaires and VAS analysis showed lower pain felt, lower intake of pain drugs and lower infection 
rate in the Group A than the Group B. Analysis of coast showed lower dressing change in Group A than 
the Group B. Conclusion: We believe that the use of tabotamp is a very viable alternative to improve healing. 
(www.actabiomedica.it)
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Introduction
Since the 1950s, oxidised regenerate cellulose 
(TABOTAMP®) has been successfully applied for lo-
cal haemostasis in intra- or post-operative bleeding 
complications. The scope of this medical product is 
large and it has found its place in oral and maxillofa-
cial surgery. 
Split-thickness skin graft are often used for cov-
ering large losses of skin. The removal of the skin 
produces a wound in turn that must be medicated to 
allow rapid healing. To promote a fast and an easy re-
epithelialization of the donor site numerous types of 
dressing are used.
Occlusive dressings are able to promote a fast re-
covery than non-occlusive dressing, with a lower rate 
of infections (1, 2). Numerous studies have been evalu-
ated to compare benefits of different dressings, such 
as hydrocolloids (3, 4), gauze impregnated with sub-
stances that improve re-epithelialization (5, 6), hydro-
gels (7), Vaseline gauze (8), but actually a comparison 
between Tambotamp fibrillar and vaseline gauzes has 
not yet been investigate. This study was designed after 
a dressing made with tabotamp in a patient who was 
taking anticoagulant therapy for mechanical mitral 
valve subjected to skin graft: the donor site was medi-
cated with tabotamp and the authors noted a reduction 
in healing time and better postoperative management.
Tabotamp was compared with vaseline gauzes be-
cause vaseline gauze is generally used as a method of 
comparison to other medications. Both are occlusive 
dressings.
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Materials and methods
In the year 2002 a patient with mechanical mitral 
valve was subjected to skin graft in our Operative Unite. 
We applied Tabotamp fibrillar in the donor site to get 
a better and faster hemostasis. Tabotamp fibrillar is a 
sponge-like collagen product used in surgical procedures 
to facilitate the monitoring of small haemorrhages when 
ligation or other conventional hemostatic control meth-
ods are ineffective. In the days after the surgery we not-
ed a reduction in healing time and better management 
postoperative. After this result, the authors have made 
this study assuming that the use of Tabotamp could be a 
good dressing in patients undergoing skin graft.
In the period between 2003 and 2011, 276 pa-
tients were underwent to split-thickness skin grafting 
in our Operative Unit. Skin grafts were performed to 
treat post-traumatic tissue losses, burns, diabetic and 
venous leg ulcers. All procedures were in according to 
the Declaration of Helsinki and all patients signed an 
informed consent.
We divided all patients into two groups: Group A 
and Group B. The area of removal of skin was treated 
with Tabotamp fibrillary in patients in Group A, and 
with Vaseline gauzes in patients of Group B.
We treated trauma, venous ulcers, diabetic ulcers, 
burns. The recruitment of patients in each group and 
in each subgroup was conducted by alternating first 
Group A and then Group B in every admission: for 
example in case of two skin graft for trauma, one was 
been allocated in the Group A and another in Group B.
The treated areas (donor site) measured between 4 
x 8 cm and 5 x 15 cm . The donor areas were identified 
in all cases in the anterolateral face of the thigh. 
All patients signed an informed consent regarding 
the proposed surgery. 
The skin was taken by donor site with the use of 
an electric dermatome with a thickness of 0,4 mm. 
Surgical procedures were performed under local anes-
thesia (lidocaine).
At the end of removal of skin phase, the donor 
area has been always compressed with sterile gauze 
soaked in saline solution to decrease the bleeding for 
ten minutes.
Fibrillar Tabotamp or Vaseline gauzes were ap-
plied in the donor area in the patients of respective 
Groups. Steril gauzes were applied and a moderate 
compressive dressing was subsequently performed in 
all patients.
Antibiotic therapy was administered intra and 
post-operative for 7 days (amoxicillin and clavulanate 
or azithromycin if allergic).
The dressing stayed in situ for 6 days and was sub-
sequently removed with the help of irrigation of sodi-
um Hypochlorite solution. Tabotamp fibrillar (Group 
A) was not removed while the vaseline gauzes (Group 
B) was removed and replaced. The area was again med-
icated with this modality every three days.
We recorded the presence of excess fluid, infec-
tion and other situations that could slow down the 
healing of the donor site
All patients were given a questionnaire (9) to as-
sess the presence of pain and a VAS (Visual Analog 
Scale) after every the dressing change. The question-
naire was filled at home.
Results were analyzed with Student’s T test to 
compare the average of time-healing. A probability 
value (p) less than 0,05 was considered significant. 
The analyses were performed in GESS 2006 statistical 
software.
Results
In both groups the donor area has reached a com-
plete re-epithelialization in 7 to 20 days.
Table 1. Patients
 Group A: Tabotamp Group B: Vaseline Gauze
 138 patients 138 patients
Traumas Burns Diabetic ulcers Venous leg ulcers Traumas Burns Diabetic ulcers Venous leg ulcers
57 patients 22 patients 24 patients 35 patients 57 patients 22 patients 24 patients 35 patients
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Group A
The process of healing of the donor area was 12 
days on average (range 10-15) in patients who received 
treatment with Tabotamp fibrillar. Four patients re-
moved them dressing before sixth day so it was not 
possible to assess the effectiveness of medications and 
we excluded them from the study. We recorded no in-
fections.
Group B
The patients treated with vaseline gauzes healed 
in 19 (13-24) days on average. It was not possible to 
evaluate the effectiveness of medication in eight cases 
because patients removed the dressing before the sixth 
postoperative day. We recorded the presence of exudate 
and superficial infection in 8 patients. An antibiogram 
showed the presence of Pseudomonas Aeuriginosa and 
Staphylococcus Aureus. In these patients the healing 
process was completed after 25 days (on average).
VAS analysis
The data of VAS showed an average of 2.25 in 
Group A (range 0 to 2.8). The average of Group B was 
6.8 (range 4 to 7.9) (p<0,05). This difference was pre-
sent because in the Group A it was not necessary to re-
move the tabotamp and so no mechanical stimulation 
of the wound bed was present during dressing change. 
Questionnaires analysis
The analysis of questionnaires showed patients in 
the GroupA do not taken analgesic drugs and the pain 
felt within 6 hours after dressing change do not intake 
the normal activity.
The drug most assumed in Group B was paraceta-
mol (73 patients), followed by Ketoprofen (28 pa-
tients). Pain felt in the first two dressings change had a 
negative impact in 82 patients in the Group B
The differences between the two groups in terms 
of time-healing were statistically significant (p<0,05).
Costs analysis
The average cost of a sheet of tabotamp is about 
86 Eur. The use of tabotamp, on the other hand, re-
sulted in a reduction of the accesses in the clinic for the 
dressings: Group A of all patients were required with 
about 2 dressings less. In our unit the average time of 
a change in medication surgery (including patient reg-
istration and compilation of the report) is estimated to 
be about 15 minutes. We have therefore spared totally 
4140 minutes of dressing change.
In addition to this evidence, the treated group had 
no infections.
Table 2. Questionnaire for pain
1)  After the dressing change, in how much time the pain dis-
appeared or was alleviated?
2)  Have you taken analgesics within 6 hours after the medica-
tion?
 Yes / No
 a.  If you answered YES to the previous question, please 
indicate who has taken drugs and dosage: _____________
3)  The pain felt during the dressing change within 6 hours 
after affects your ability to walk?
 Yes / No
4)  The pain felt during the dressing change within 6 hours 
after affects your ability to work?
 Yes / No
5)  The pain felt during the dressing change within 6 hours 
after affects your ability to sleep?
 Yes / No
6)  The pain felt during the dressing change within 6 hours 
following affect the taste of living?
 Yes / No
7)  The pain felt during the dressing change within 6 hours 
following affects the relationship with other people?
 Yes / No
8)  The pain felt during the dressing change within 6 hours 
after affects your mood?
 Yes / No
Figure 1. Visual Analog Scale
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Discussion
The fibrillar tabotamp is a fibrous absorbable he-
mostatic oxidized regenerated cellulose and is used in 
surgical procedures to facilitate the monitoring of small 
haemorrhages (10) when ligation or other conventional 
hemostatic control methods are ineffective (11-13).
Tabotamp has a bactericidal action because, posi-
tioned in situ, creates an acidic environment (pH <4), 
which many strains of bacteria do not survive (14-16).
It is a product that is largely used in our operating 
unit. During a skin graft, the sampling area tends to 
bleed because of the damage to the dermal vessels (9, 
17-19). A good hemostatic control is the first step to 
proper healing of the donor area. Achieving a good he-
mostasis (14, 15) and a good dressing are key to rapid 
healing and scarring satisfactory (20).
Often the correct evaluation of the healing of the 
donor area is very complex because the epithelializa-
tion proceeds very subjective depending on the pa-
tient’s clinical condition and because it focuses on the 
end result of the graft into the recipient. In any case, 
several studies have been proposed for a correct man-
agement of the donor site (1, 2, 16).
Assadian &Co. compared methacrylate and car-
boxymethylcellulose in 34 patients with lower pain but 
no difference in terms of number of dressing changes 
(5).
Davidson & Co. compared alginate-based dress-
ing and keratin dressing showing that alginate was as-
sociated with a benefit in terms of re-epithelialization 
in patients older than 50 years (6).
Even Aquacel is often used for the dressing in situ 
with excellent results in terms of healing of the donor 
site (21), but a comparision between Tabotamp and 
Vaseline gauze has not yet been done.
Conclusions
Tabotamp is a versatile product that provides a 
good coverage and antibacterial proprieties with good 
scarring. There were no infections, more rapid heal-
ing and a smaller number of dressings to perform with 
4140 minutes speared and with lower pain felt by the 
patients.
The use of fibrillar tabotamp produces a number 
of benefits including: less pain, faster healing and a 
saving of time and money due to a lower number of 
dressings change. Both the smaller number of medica-
tions, both the reduced intake of pain drug, both the 
reduced rate of infections result in cost savings for the 
health system and greater compliance for the patient.
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